Author:
Song I. H.,Poddubnyy D. A.,Rudwaleit M.,Sieper J.
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference51 articles.
1. ASAS/EULAR recommendations for the management of ankylosing spondylitis;Zochling;Ann Rheum Dis,2006
2. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study;Van der Heijde;Arthritis Rheum,2005
3. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial;Dougados;Rheumatology (Oxford),1999
4. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis;Barkhuizen;J Rheumatol,2006
5. Are classification criteria for spondylarthropathy useful as diagnostic criteria?;Amor;Rev Rhum Engl Ed,1995
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献